Literature DB >> 32474122

Exploration of a novel prognostic risk signatures and immune checkpoint molecules in endometrial carcinoma microenvironment.

Jinhui Liu1, Sipei Nie1, Zhipeng Wu2, Yi Jiang1, Yicong Wan1, Siyue Li1, Huangyang Meng1, Shulin Zhou3, Wenjun Cheng4.   

Abstract

In this study, we devoted to investigate immune-related genes and tumor microenvironment (TME) in EC based on The Cancer Genome Atlas (TCGA) database. In total 799 up-regulated and 139 down-regulated immune-related and differentially expressed genes in EC were investigated for functional annotations and prognosis. By a conjoint Cox regression analysis, we built two risk models for OS and DFS, as well as the consistent nomograms. Immune-related pathways were revealed mostly enriched in the low-risk group. By further analyzing TME based on the risk signatures, the higher immune cell infiltration and activation, lower tumor purity and higher tumor mutational burden were found in low-risk group, which presented a better prognosis. Both the expression and immunophenoscore of immune checkpoints PD-1, CTLA4, PD-L1 and PD-L2 increased significantly in low-risk group. These findings may provide new ideas for novel biomarkers and immunotherapy targets in EC.
Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Endometrial carcinoma (EC); Prognostic model; The cancer genome atlas (TCGA); Tumor microenvironment

Year:  2020        PMID: 32474122     DOI: 10.1016/j.ygeno.2020.05.022

Source DB:  PubMed          Journal:  Genomics        ISSN: 0888-7543            Impact factor:   5.736


  15 in total

1.  An immune-related prognostic signature for thyroid carcinoma to predict survival and response to immune checkpoint inhibitors.

Authors:  Pu Wu; Wei Sun; Hao Zhang
Journal:  Cancer Immunol Immunother       Date:  2021-08-16       Impact factor: 6.968

2.  Identification of a Novel Tumor Microenvironment-Associated Eight-Gene Signature for Prognosis Prediction in Lung Adenocarcinoma.

Authors:  Chao Ma; Huan Luo; Jing Cao; Xiangyu Zheng; Jinjun Zhang; Yanmin Zhang; Zongqiang Fu
Journal:  Front Mol Biosci       Date:  2020-09-23

3.  Identification of molecular subtypes premised on the characteristics of immune infiltration of endometrial cancer.

Authors:  Cong Liu; Yan Zhang; Chen Hang
Journal:  Ann Transl Med       Date:  2022-03

4.  DNA methylation-based lung adenocarcinoma subtypes can predict prognosis, recurrence, and immunotherapeutic implications.

Authors:  Feng Xu; Lulu He; Xueqin Zhan; Jiexin Chen; Huan Xu; Xiaoling Huang; Yangyi Li; Xiaohe Zheng; Ling Lin; Yongsong Chen
Journal:  Aging (Albany NY)       Date:  2020-11-21       Impact factor: 5.682

5.  A Novel Kinase Inhibitor AX-0085 Inhibits Interferon-γ-Mediated Induction of PD-L1 Expression and Promotes Immune Reaction to Lung Adenocarcinoma Cells.

Authors:  Jusong Kim; Haeyeon Jang; Gyu Jin Lee; Yelim Hur; Juhee Keum; Jung Ki Jo; Si-Eun Yun; Sung Jun Park; Young Jun Park; Myeong Jun Choi; Kye-Seong Kim; Jaesang Kim
Journal:  Cells       Date:  2021-12-22       Impact factor: 6.600

6.  DLC1 Is a Prognosis-Related Biomarker Correlated With Tumor Microenvironment Remodeling in Endometrial Carcinoma.

Authors:  Yalan Wu; Li-E Zheng; Shumin Chen; Chengyu Lv; Yuxiu Huang
Journal:  Front Oncol       Date:  2022-02-11       Impact factor: 6.244

7.  Bioinformatic profiling identifies prognosis-related genes in the immune microenvironment of endometrial carcinoma.

Authors:  Pu Cheng; Jiong Ma; Xia Zheng; Chunxia Zhou; Xuejun Chen
Journal:  Sci Rep       Date:  2021-06-15       Impact factor: 4.379

8.  Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.

Authors:  JinHui Liu; ChengJian Ji; Yichun Wang; Cheng Zhang; HongJun Zhu
Journal:  Cancer Cell Int       Date:  2021-07-10       Impact factor: 5.722

9.  Immune-related gene ANGPT1 is an adverse biomarker for endometrial carcinoma.

Authors:  Binbin Nong; Tongye Su; Mingyang Jin; Jintai Huang; Aimin Huang; Dalang Fang; Jie Wei
Journal:  Transl Cancer Res       Date:  2021-06       Impact factor: 1.241

10.  Identification of an eleven-miRNA signature to predict the prognosis of endometrial cancer.

Authors:  Jing Lu; Jianqiang Liang; Mengting Xu; Zhipeng Wu; Wenjun Cheng; Jie Wu
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.